Updated on 19 October 2026
Anticodon Analytics
CEO at TAMASERV GmbH
Mainz, Germany
About
Focussing on the quantitative LC-MS Analysis of RNA Modifications in all RNA-Species, we are looking for an opportunity to support a partner in the development or improvement of a new protein expression system. Our approach is agnostic, and we will provide e.g. visibility against a targeted optimal tRNA Pool to better steer the production process.
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Quantification of RNA Modification
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Oliver Dening
CEO at TAMASERV GmbH
Mainz, Germany
Project cooperation
RNA structure and viral genomics partner for antiviral discovery
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Michael Wolfinger
Founder & Principal Scientist, RNA Forecast e.U. at RNA Forecast e.U.
Vienna, Austria
Project cooperation
AI-Driven Bioinformatics & Multimodal Clinical Decision Support Systems Capabilities
Esra CINAR
R&D Project Manager at Idea Teknoloji
Istanbul, Türkiye